What is NDC 62559-207?

62559-207 is the product NDC for Memantine And Donepezil Hydrochlorides, Memantine hydrochloride 21 mg/1; Donepezil hydrochloride 10 mg/1 capsule, extended release, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Memantine hydrochloride, Donepezil hydrochloride.

ANI Pharmaceuticals, Inc., NDC labeler code 62559. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Memantine And Donepezil Hydrochlorides?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Memantine And Donepezil Hydrochlorides NDC 62559-207

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-207Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0207Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-207-30	6255902073062559020730	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-207-30)Marketed from Jan 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Memantine And Donepezil Hydrochlorides
Generic name (nonproprietary): memantine and donepezil hydrochlorides
Active ingredients: Memantine hydrochloride — 21 mg/1Donepezil hydrochloride — 10 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 62559
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208237
Marketing start: Jan 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 62559-207_cd8d0e95-24ac-43e1-9d43-bb081b4f341eSPL ID cd8d0e95-24ac-43e1-9d43-bb081b4f341eSPL set ID c42a995d-cd0f-466c-8f47-43c7f32d9675RxCUI 1805420UNII JY0WD0UA60, 3O2T2PJ89DUPC 0362559207300
Pharmacologic class: Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559020730 followed by a unit qualifier and the quantity

Package 62559-0207-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2025.

Indications (excerpt from the label)

Memantine and donepezil hydrochlorides extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer's type in patients stabilized on 10 mg of donepezil hydrochloride once daily. Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62559-207

What is NDC 62559-207?: 62559-207 is the product NDC for Memantine And Donepezil Hydrochlorides, Memantine hydrochloride 21 mg/1; Donepezil hydrochloride 10 mg/1 capsule, extended release, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Memantine And Donepezil Hydrochlorides.
What is the active ingredient?: Memantine hydrochloride, Donepezil hydrochloride.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 62559. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Memantine And Donepezil Hydrochlorides?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.